Butyric Acid

Butyric Acid

SCHEMBL2818571

CCCC(=O)O.CCCCCC.CCN(CC)CC.CO

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.59
HDAC3 O15379 1/20 0.59
HDAC1 Q13547 1/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
AKR1B1 P15121 1/20 0.58
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 4/20 0.56
TDP1 Q9NUW8 4/20 0.56
PTPN1 P18031 3/20 0.56
ALDH1A1 P00352 3/20 0.56
KMT2A Q03164 3/20 0.56
TLR2 O60603 2/20 0.56
FABP4 P15090 2/20 0.56
MEN1 O00255 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL618898 0.98 FFAR3 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Heptane SCHEMBL3485862 0.95 GPR84 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL5477656 0.93 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL5904081 0.91 FFAR3 (0.65) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL834319 0.91 FFAR3 (0.72) FFAR3HDAC3HDAC1HDAC2HDAC8
Hexanoate SCHEMBL3411666 0.88 AKR1B1 (0.76) AKR1B1GPR84PPARGPPARDPPARA
Butyric Acid SCHEMBL8517702 0.88 FFAR3 (0.68) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL608115 0.88 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL4783360 0.88 FFAR3 (0.77) FFAR3HDAC3HDAC1HDAC2HDAC8
Heptanoate SCHEMBL3410001 0.86 GPR84 (0.77) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938249-B2 Anti-amyloid compounds containing benzofurazan TREVENTIS CORPORATION (US) 2018-04-10 US disclosed
US-20170174641-A1 ANTI-AMYLOID COMPOUNDS CONTAINING BENZOFURAZAN TREVENTIS CORPORATION (US) 2017-06-22 US disclosed
US-8288428-B2 Compounds as cannabinoid receptor ligands ABBOTT LABORATORIES (US) 2012-10-16 US disclosed
US-20100249087-A1 COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249087-A1 COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, GPR18 FFAR3 131/4885HDAC3 1436/4885HDAC1 1280/4885
US-20170174641-A1 ANTI-AMYLOID COMPOUNDS CONTAINING BENZOFURAZAN PRNP, PSEN1, APP FFAR3 3934/4885HDAC3 2885/4885HDAC1 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.